Skip to main content

Closed

PPCB: Propanc Biopharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-161.1%

Financially safe

Stretched

Debt / equity0.16×

Interest coverage-27.9×

Current ratio2.37×

Propanc Biopharma, Inc.

PPCBNASDAQ Capital Market·USD·Closed

Propanc Biopharma, Inc.

PPCBNASDAQ·USD·Closed

$1.01

−2.88%

$1.01

−$0.03 (2.88%)

52W Range

0thpctl

Volume

0.01×avg

Mkt Cap

883115USD

P/E

-0.0TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.01×avg

Market Cap

883115USD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings